SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000849146-14-000077
Filing Date
2014-11-06
Accepted
2014-11-06 16:04:06
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lfvn_093014x10q.htm 10-Q 572481
2 CEO CERTIFICATION lfvn_093014xex311.htm EX-31.1 11533
3 CFO CERTIFICATION lfvn_093014xex312.htm EX-31.2 11510
4 CEO CERTIFICATION lfvn_093014xex321.htm EX-32.1 5665
5 CFO CERTIFICATION lfvn_093014xex322.htm EX-32.2 5642
  Complete submission text file 0000849146-14-000077.txt   3164835

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lfvn-20140930.xml EX-101.INS 300220
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20140930.xsd EX-101.SCH 21735
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20140930_cal.xml EX-101.CAL 52154
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20140930_def.xml EX-101.DEF 84550
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20140930_lab.xml EX-101.LAB 358591
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20140930_pre.xml EX-101.PRE 192187
Mailing Address 9815 S. MONROE STREET SUITE 100 SANDY UT 84070
Business Address 9815 S. MONROE STREET SUITE 100 SANDY UT 84070 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35647 | Film No.: 141200623
SIC: 2834 Pharmaceutical Preparations